BioXcel Therapeutics, Inc. (BTAI) Financials

BTAI Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 100.4 million 141.1 million
2023-06-30 140.1 million 134.2 million
2023-03-31 180.1 million 127.1 million
2022-12-31 205.9 million 129.1 million

BTAI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -37.6 million 4.0 million
2023-06-30 -38.2 million 6.1 million
2023-03-31 -52.4 million 4.9 million
2022-12-31 -38.6 million 4.5 million

BTAI Net Income

No data available :(

BTAI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 90.0 million - 529000
2023-06-30 127.5 million 96.8 million 949000
2023-03-31 165.5 million 95.1 million 1.0 million
2022-12-31 193.7 million 93.1 million 1.1 million

BTAI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 29.3 million
2023-06-30 29.2 million
2023-03-31 28.6 million
2022-12-31 28.1 million

BTAI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 19.6 million 21.4 million 3.0 million
2023-06-30 20000 27.0 million 21.1 million 4.8 million
2023-03-31 20000 27.8 million 23.6 million -
2022-12-31 - 32.5 million 20.7 million 31.0 million

BTAI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 341000 512000
2023-06-30 457000 26000
2023-03-31 206000 9000
2022-12-31 238000 9000

BTAI

Price: $2.63

52 week price:
1.91
29.56

Earnings Per Share: -6.15 USD

P/E Ratio: -0.51

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 510800

Market Capitalization: 80.4 million

Links: